• Policy
• Basic refund type-drugs granted early RSA termination
• by Lee, Tak-Sun Dec 20, 2024 05:46am

• Policy
• Cinacalcet impurities spread…Huons recalls product
• by Lee, Hye-Kyung Dec 19, 2024 05:53am

• Policy
• Sanofi signs PVA negotiations for hemophilia drug 'Alprolix'
• by Lee, Tak-Sun Dec 19, 2024 05:52am

• Policy
• Hyperphosphatemia treatments undergo generation change
• by Lee, Tak-Sun Dec 19, 2024 05:52am

• Company
• 'Vyloy' to expand treatment options for gastric cancer
• by Whang, byung-woo Dec 19, 2024 05:52am

• Policy
• Prior notification of drug permit changes extended to 2025
• by Lee, Hye-Kyung Dec 19, 2024 05:52am

• Company
• Kuhnil signs licensing agreement with Mochida
• by Whang, byung-woo Dec 18, 2024 05:55am

• Opinion
• [Reporter’s View] ERP hits industry again
• by Eo, Yun-Ho Dec 18, 2024 05:55am

• Company
• Celltrion launches subsidiary 'BioSolutions' for CDMO
• by Cha Jihyun Dec 18, 2024 05:55am

• Company
• Numerous K-Bio drugs secure FDA ODD
• by Son, Hyung Min Dec 18, 2024 05:55am